The U.S. Court of Appeals for the First Circuit recently provided important clarity—and welcome relief—for clinical laboratories facing False Claims Act (“FCA”) allegations based on a lack of medical ...
Stakeholder comments on the draft policy requested that the State move more aggressively, and that the DEC immediately establish enforceable effluent limitations and require monitoring across all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback